Heartflow (NASDAQ:HTFL) Insider Campbell Rogers Sells 9,219 Shares of Stock

Heartflow, Inc. (NASDAQ:HTFLGet Free Report) insider Campbell Rogers sold 9,219 shares of the business’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $28.34, for a total value of $261,266.46. Following the transaction, the insider owned 78,731 shares of the company’s stock, valued at approximately $2,231,236.54. The trade was a 10.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Campbell Rogers also recently made the following trade(s):

  • On Wednesday, April 1st, Campbell Rogers sold 64,533 shares of Heartflow stock. The stock was sold at an average price of $24.64, for a total value of $1,590,093.12.
  • On Thursday, March 19th, Campbell Rogers sold 64,533 shares of Heartflow stock. The stock was sold at an average price of $25.69, for a total value of $1,657,852.77.

Heartflow Stock Up 2.9%

Heartflow stock opened at $27.38 on Thursday. Heartflow, Inc. has a 52 week low of $20.13 and a 52 week high of $41.22. The business has a 50-day simple moving average of $27.45 and a 200 day simple moving average of $28.57. The stock has a market cap of $2.36 billion and a price-to-earnings ratio of -8.80.

Heartflow (NASDAQ:HTFLGet Free Report) last posted its earnings results on Thursday, May 14th. The company reported ($0.16) EPS for the quarter, topping the consensus estimate of ($0.24) by $0.08. The business had revenue of $52.59 million for the quarter. Heartflow’s revenue was up 41.3% compared to the same quarter last year. On average, research analysts anticipate that Heartflow, Inc. will post -0.78 earnings per share for the current year.

Institutional Investors Weigh In On Heartflow

Several hedge funds have recently added to or reduced their stakes in the company. Bank of America Corp DE lifted its stake in Heartflow by 28.8% during the first quarter. Bank of America Corp DE now owns 111,702 shares of the company’s stock worth $2,718,000 after purchasing an additional 24,964 shares during the last quarter. Janus Henderson Group PLC lifted its stake in shares of Heartflow by 152.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock valued at $53,063,000 after acquiring an additional 1,315,416 shares during the last quarter. California State Teachers Retirement System lifted its stake in shares of Heartflow by 41.9% in the 1st quarter. California State Teachers Retirement System now owns 29,371 shares of the company’s stock valued at $715,000 after acquiring an additional 8,678 shares during the last quarter. Royal Bank of Canada lifted its stake in shares of Heartflow by 24.4% in the 1st quarter. Royal Bank of Canada now owns 137,421 shares of the company’s stock valued at $3,343,000 after acquiring an additional 26,912 shares during the last quarter. Finally, Rock Springs Capital Management LP lifted its stake in shares of Heartflow by 106.2% in the 1st quarter. Rock Springs Capital Management LP now owns 572,500 shares of the company’s stock valued at $13,929,000 after acquiring an additional 294,800 shares during the last quarter.

Analysts Set New Price Targets

HTFL has been the subject of several research analyst reports. Wells Fargo & Company lifted their price target on Heartflow from $35.00 to $37.00 and gave the stock an “overweight” rating in a research note on Friday, May 15th. JPMorgan Chase & Co. dropped their price target on Heartflow from $40.00 to $35.00 and set an “overweight” rating for the company in a research note on Thursday, March 19th. William Blair initiated coverage on Heartflow in a research note on Monday, May 4th. They set an “outperform” rating for the company. Finally, Canaccord Genuity Group dropped their price target on Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a research note on Friday, May 15th. Six analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $37.00.

View Our Latest Stock Analysis on Heartflow

Heartflow Company Profile

(Get Free Report)

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

Featured Articles

Insider Buying and Selling by Quarter for Heartflow (NASDAQ:HTFL)

Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.